Abstract

Plants serve as a boundless source of raw materials for pharmaceuticals and have been used as an important source of medicine for several years. Identifying natural compounds from medicinal plants is useful for the discovery of novel therapeutic agents. Tylophora indica is perennial climber which possess many medicinal properties. Although it also contains many bioactive compounds which have role in various biological activity such as anti-inflammatory activity, anti-oxidant activity, and anti-cancer activity. The present study aimed to identify the bioactive compounds from methanolic and hexane extract of the leaves, stems, and roots of T. indica using GC-MS analysis. GC-MS analysis was performed by using standard protocols. Willey and NIST libraries were used in the identification of components, and their retention indices were compared. The GC-MS analysis revealed the presence of various prevailing compounds like Levomenthol, 2-Butanone, 3,3-dimethyl-1-(methylsulfonyl)-,O[(methylamino)carbonyl] oxime, Squalene, 5–methyl–2–(1–methylethyl)–(1α,2β,5β)– cyclohexanol, Oleic acid and 2-propyloxirane etc. These identified compounds play a vital role in various biological activities which were confirmed by Dr. Duke’s phytochemical and ethnobotanical databases (https://phytochem.nal.usda.gov/). The findings of this study demonstrate that T. indica is a rich source of numerous bioactive compounds that can be useful in halting the progression of several disorders.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.